"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA." Lancet , 2023;402:529-544
Most patients begin after a standard health review and, if needed, basic lab work to understand metabolic baselines
Tirzepatide fridge storage typically maintains potency for 28-42 days
At 24 weeks, liver-fat content (measured by non-invasive imaging, MRI-PDFF) fell by 81.4% on 8 mg and 82.4% on 12 mg, compared with a small increase in those participants on the placebo
If you're familiar with reconstituting other peptides with bacteriostatic water , the process will feel familiar
Susan Sweeney, Amgen's senior vice president and head of obesity, said, Weight loss is important, but finding a way for patients to manage their disease long term and maintain their weight is even more important. Finding ways to reduce fat while preserving muscle mass is another competitive advantage that next-generation obesity drugs can offer